hibit
diminish
even
lost
fusion
activ
stage
fusion
although
effect
cell
surfac
express
coimmunoprecipit
assay
mutant
result
decreas
detect
hnf
complex
compar
wildtyp
f
protein
conclus
motif
import
influenc
fusion
activ
integr
indispens
membran
fusion
membran
result
deliveri
viral
genom
singlestrand
nonseg
negativesens
rna
cytoplasm
target
cell
two
type
virionassoci
surfac
glycoprotein
ie
hemagglutininneuraminidas
hn
protein
fusion
f
protein
cooper
facilit
process
hn
glycoprotein
respons
initi
bind
viru
target
cell
wherea
f
glycoprotein
involv
disrupt
hostcel
plasma
membran
direct
induct
membran
fusion
f
protein
classifi
type
integr
membran
protein
synthes
inact
precursor
design
f
activ
proteolyt
cleavag
transport
golgi
membran
disulfidelink
heterodim
f
f
sever
structur
featur
protein
known
import
fusion
activ
stretch
hydrophob
amino
acid
amino
terminu
f
subunit
term
fusion
peptid
consid
respons
insert
host
cell
membran
initi
fusion
process
addit
heptad
repeat
region
ie
hra
hrb
f
polypeptid
believ
import
role
membran
fusion
hra
locat
carboxyl
termin
fusion
peptid
hrb
locat
immedi
upstream
transmembran
region
upon
trigger
domain
undergo
conform
chang
form
stabl
coil
pull
viral
target
cell
membran
togeth
larg
interven
region
hra
hrb
sequenc
analysi
indic
contain
leucin
zipperlik
motif
highli
conserv
motif
character
period
repeat
leucin
isoleucin
residu
everi
amino
acid
nonpolar
residu
found
first
fourth
posit
display
wheel
previou
studi
motif
differ
paramyxoviru
system
suggest
region
import
fusion
activ
howev
whether
leucin
zipperlik
motif
locat
hra
hrb
f
protein
play
import
role
fusion
activ
yet
determin
investig
effect
domain
fusion
activ
point
mutat
introduc
use
sitedirect
mutagenesi
substitut
heptad
residu
amino
acid
motif
alanin
residu
addit
highli
conserv
middl
heptad
leucin
residu
ie
replac
alanin
variou
combin
effect
fusion
activ
cell
surfac
express
hnf
interact
mutat
f
protein
examin
data
show
mutant
whether
individu
combin
caus
reduct
cell
surfac
express
level
f
led
decreas
fusogen
activ
step
membran
fusion
thu
seem
defect
fusogen
activ
mutat
f
protein
relat
decreas
hnf
interact
cell
surfac
cell
virus
cell
obtain
american
type
cultur
collect
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
usa
supplement
fetal
calf
serum
fc
fresh
human
erythrocyt
rbc
obtain
physic
examin
center
qilu
hospit
shandong
univers
studi
approv
institut
review
board
shandong
univers
written
inform
consent
obtain
patient
hospit
ethic
committe
approv
experi
wildtyp
wt
vaccinia
viru
use
quantifi
cell
fusion
recombin
vaccinia
viru
gener
gift
dr
bernard
moss
use
provid
rna
polymeras
rna
polymeras
express
system
virus
maintain
cell
hn
f
gene
clone
pbluescript
sk
pbsk
bamh
site
gener
pbskhn
pbskf
previous
describ
recombin
plasmid
purifi
escherichia
coli
cell
use
enza
plasmid
miniprep
kit
omega
biotek
inc
norcross
ga
usa
wt
mutat
f
protein
express
cell
use
vaccinia
rna
polymeras
express
system
previous
describ
experi
except
spectrofluorometr
analysi
lipid
mix
cell
seed
plate
day
prior
use
cellswel
monolay
cell
infect
recombin
vaccinia
viru
express
multipl
infect
moi
h
c
co
incub
transfect
perform
recommend
mirza
et
al
use
lipofectamin
tm
invitrogen
plasmid
sitedirect
mutagenesi
perform
accord
protocol
previous
describ
f
recombin
plasmid
vector
use
templat
pcr
mutagenesi
gener
alanin
codon
substitut
two
pair
reversecompl
mutagenesi
primer
sangon
biotech
co
ltd
shanghai
china
design
mutat
target
amino
acid
primer
follow
sequenc
start
nucleotid
mutant
site
underlin
primer
sequenc
tat
gat
cta
gca
ttt
aca
gaa
tga
ttc
tgt
aaa
tgc
tag
atc
ata
gaa
tca
ata
aag
gcg
aga
gtt
ata
c
tat
aac
tct
cgc
ctt
tat
tga
ttc
pbskf
plasmid
digest
kpn
use
templat
gener
one
pcr
fragment
primer
complement
complement
pbskf
plasmid
digest
use
templat
gener
pcr
fragment
primer
complement
complement
two
pcr
product
homolog
end
transform
e
coli
cell
select
ampicillin
resist
identif
coloni
carri
mutat
f
gene
facilit
screen
presenc
uniqu
restrict
site
ie
kpn
site
site
final
mutat
f
protein
gene
sequenc
entireti
verifi
desir
mutat
chang
f
protein
present
singl
mutant
obtain
procedur
doubl
tripl
mutant
made
sequenti
mutagenesi
previous
mutagen
templat
mutat
verifi
dna
sequenc
success
introduc
monolay
cell
grown
plate
cotransfect
cdna
encod
wt
mutat
f
protein
along
hn
protein
empti
vector
alon
total
amount
dna
per
well
h
posttransfect
transfect
monolay
wash
phosphatebuff
salin
pb
fix
methanol
min
cell
stain
giemsa
accustain
sigma
chemic
co
syncytium
observ
field
view
syncytia
nuclei
count
repres
field
captur
invert
microscop
olympu
quantif
syncytia
accomplish
measur
syncytiacov
area
random
field
compar
total
area
field
area
quantifi
use
analysi
tool
adob
photoshop
contentmix
assay
base
cytoplasm
activ
report
gene
essenti
perform
previous
describ
slight
modif
one
popul
cell
infect
recombin
vaccinia
viru
describ
cotransfect
desir
f
hn
gene
second
popul
cell
infect
wt
vaccinia
viru
moi
transfect
per
well
plasmid
carri
gene
control
promot
h
posttransfect
cell
remov
well
trypsin
trypsin
edta
gibco
wash
pellet
resuspend
complet
medium
equal
number
popul
mix
triplic
microtit
plate
incub
c
h
cell
lyse
lysat
assay
activ
accord
procedur
highsensit
assay
kit
stratagen
la
jolla
calif
usa
extent
fusion
quantifi
measur
absorb
nm
plate
reader
biotek
instrument
inc
background
fusion
obtain
cell
transfect
compar
amount
vector
alon
subtract
dye
transfer
assay
perform
previous
describ
fresh
human
rbc
wash
resuspend
cold
pb
hematocrit
incub
octadecyl
rhodamin
b
invitrogen
mgml
ethanol
min
room
temperatur
dark
three
volum
complet
medium
ad
incub
continu
addit
min
rbc
wash
resuspend
pb
contain
cacl
mgcl
pbscm
hematocrit
downstream
experi
h
incub
cell
monolay
coexpress
wt
mutat
f
hn
protein
wash
treat
mu
per
ml
neuraminidas
sigma
chemic
co
dmem
h
c
cell
wash
overlaid
rbc
c
min
occasion
gentl
agit
cell
wash
incub
min
c
final
cell
wash
immedi
visual
count
photograph
use
nikon
fluoresc
microscop
rbc
label
way
dye
transfer
assay
monolay
cell
grown
dish
infect
moi
per
well
h
c
wash
twice
dmem
gibco
cell
cotransfect
wt
mutat
f
hn
gene
plasmid
encod
hn
f
protein
kept
total
transfect
dna
kept
h
posttransfect
monolay
wash
pb
subject
neuraminidas
treatment
describ
cell
wash
twice
incub
ml
rbc
hematocrit
min
c
excess
unbound
rbc
remov
rbccell
complex
transfer
dish
new
eppendorf
tube
incub
min
c
solut
pb
contain
edta
rbccell
complex
wash
place
ice
use
fifti
microlit
rbc
acceptor
cell
suspens
inject
cuvett
contain
ml
pb
prewarm
c
fluoresc
chang
continu
measur
use
spectrofluoromet
hitachi
tokyo
japan
time
resolut
excit
emiss
wavelength
respect
normal
data
percent
fluoresc
dequench
fdq
time
point
calcul
accord
follow
equat
fdq
f
f
f
f
f
f
fluoresc
intens
time
zero
given
time
point
respect
f
fluoresc
intens
presenc
triton
taken
fluoresc
infinit
dilut
probe
cell
surfac
express
wt
mutat
f
protein
examin
flow
cytometri
previous
describ
cell
transfect
plasmid
encod
wt
mutat
f
protein
h
posttransfect
monolay
detach
pellet
wash
twice
pbsfc
pb
contain
fc
incub
antif
monoclon
antibodi
millipor
dilut
pb
contain
bsa
room
temperatur
h
wash
pbsfc
remov
unbound
antibodi
cell
incub
dilut
alexa
fluor
goat
antimous
immunoglobulin
g
antibodi
proteintech
follow
wash
cell
fix
pb
contain
paraformaldehyd
c
min
wash
addit
time
cell
resuspend
ml
pb
subject
flow
cytometri
facscalibur
flow
cytomet
becton
dickinson
bioscienc
cell
transfect
vector
alon
use
control
abil
wt
mutat
f
protein
interact
hn
protein
surfac
transfect
cell
assay
use
modif
coimmunoprecipit
assay
previous
describ
monolay
grown
plate
confluenc
transfect
cdna
encod
hn
protein
well
wt
mutat
f
protein
describ
color
version
avail
onlin
ice
use
cold
pb
contain
triton
deoxychol
phenylmethylsulfonyl
fluorid
cell
lysat
clarifi
centrifug
supernat
collect
eppendorf
tube
contain
antihn
antibodi
dilut
crosslink
dynabead
protein
invitrogen
antihn
antibodi
mixtur
monoclon
antibodi
ie
obtain
abcam
mix
incub
rotat
room
temperatur
min
form
dynabeadshn
abhn
agf
ag
complex
wash
pb
use
magnet
bound
protein
releas
boil
min
resuspend
pb
incub
streptavidin
bead
pierc
overnight
c
follow
wash
bead
resuspend
gel
sampl
buffer
cell
express
vector
hn
f
alon
use
control
ensur
f
protein
coimmunoprecipit
hn
antibodi
occur
interact
hn
protein
protein
dilut
gel
sampl
buffer
presenc
separ
polyacrylamid
gel
electrophoresi
gel
equilibr
transfer
buffer
transfer
immobilonp
millipor
corp
membran
membran
block
wash
incub
primari
antibodi
either
monoclon
antibodi
specif
f
protein
mixtur
antihn
monoclon
antibodi
dilut
pbstween
nonfat
milk
overnight
c
antif
antibodi
mous
monoclon
antibodi
purchas
chemicon
intern
inc
wash
blot
incub
secondari
antibodi
goat
antimous
immunoglobulin
g
coupl
horseradish
peroxidas
zsgbbio
beij
china
dilut
pbstween
h
room
temperatur
follow
extens
wash
protein
band
detect
use
enhanc
chemiluminesc
western
blot
detect
reagent
system
amersham
bioscienc
quantif
signal
accomplish
use
fluor
imag
biorad
result
express
mean
sd
least
independ
experi
statist
analysi
perform
use
student
test
p
consid
statist
signific
leucin
zipperlik
motif
f
protein
locat
hra
hrb
amino
acid
fig
amino
acid
sequenc
region
f
protein
shown
figur
b
investig
role
leucin
zipperlik
motif
fmediat
membran
fusion
alanin
substitut
mutagenesi
heptad
residu
lvlllqi
carri
mutat
introduc
individu
combin
indic
figur
b
reason
chose
alanin
rather
amino
acid
substitut
residu
short
side
chain
believ
minim
disrupt
impact
potenti
protein
structur
locat
mutat
display
figur
c
investig
abil
differ
mutat
f
protein
induc
cellcel
fusion
presenc
hn
coexpress
differ
type
membran
fusion
assay
ie
syncytium
format
assay
contentmix
assay
lipidmix
assay
perform
first
test
mutant
f
protein
overal
level
cellcel
fusion
recombin
vaccinia
virusinfect
cell
monitor
syncytium
format
multinucl
giant
cell
observ
h
posttransfect
photomicrograph
repres
experi
exhibit
syncytia
shown
figur
cell
express
vector
wt
f
protein
alon
without
coexpress
hn
protein
use
neg
control
contrast
syncytia
observ
cell
coexpress
wt
f
hn
protein
syncytia
form
monolay
cell
coexpress
mutat
f
hn
protein
smaller
also
fewer
quantif
syncytia
express
percentag
detect
cell
coexpress
wt
f
hn
protein
shown
figur
b
three
singl
mutant
doubl
mutant
sever
debilit
syncytium
format
less
wt
f
hn
protein
wherea
mutant
display
slightli
decreas
extent
syncytium
format
wt
f
hn
level
respect
addit
mutant
result
decreas
syncytium
format
ie
wt
f
hn
level
tripl
mutant
lost
abil
form
syncytia
result
suggest
presenc
hn
coexpress
mutant
mediat
reduc
level
syncytium
format
accur
quantifi
membran
fusion
activ
mutant
perform
report
gene
assay
measur
level
content
mix
assay
cell
coexpress
wt
mutat
f
along
hn
protein
cell
transfect
plasmid
contain
gene
use
analyz
fusion
activ
result
report
figur
three
singl
mutant
doubl
mutant
markedli
diminish
fusion
activ
correspond
percentag
less
wt
f
hn
level
wherea
mutant
retain
wt
level
content
mix
mutant
reduc
fusion
activ
approxim
wt
f
level
addit
background
level
fusion
activ
wt
f
detect
remain
tripl
mutant
result
recapitul
obtain
syncytium
format
assay
data
demonstr
alanin
substitut
result
differ
level
reduct
content
mix
membran
fusion
gener
thought
includ
follow
step
hemifus
pore
format
pore
expans
alanin
substitut
leucin
zipperlik
motif
f
protein
weaken
mutant
abil
form
syncytia
induc
content
mix
variou
degre
decid
test
whether
mutant
capabl
mediat
mix
outer
leaflet
plasma
membran
often
refer
b
pbsk
pbsk
f
pbsk
f
pbsk
hn
pbsk
hn
mutant
f
gene
h
posttransfect
monolay
fix
methanol
stain
giemsa
syncytium
observ
repres
photomicrograph
syncytium
format
syncytia
indic
arrow
b
quantif
syncytia
accomplish
measur
area
cover
syncytia
compar
total
area
field
random
field
data
obtain
mutat
f
protein
express
percentag
wt
valu
valu
shown
mean
sd
separ
experi
p
p
p
intervirolog
doi
hemifus
assess
transfer
lipophil
membran
rbc
membran
cell
coexpress
wt
mutat
f
hn
protein
demonstr
figur
dye
transfer
label
rbc
underli
cell
coexpress
wt
f
hn
protein
label
rbc
incub
cell
express
pbsk
wt
f
protein
alon
extent
dye
transfer
express
averag
number
dye
transfer
event
microscop
field
presenc
hn
coexpress
overal
extent
dye
transfer
promot
mutat
f
protein
lower
wt
f
fig
b
three
singl
mutant
doubl
mutant
gave
small
number
fusion
event
almost
similar
neg
control
level
wherea
mutant
reduc
dye
transfer
event
wt
f
level
respect
mutant
caus
approxim
half
dye
transfer
wt
f
dye
transfer
event
observ
tripl
mutant
therefor
alanin
substitut
result
defect
abil
mutat
f
protein
mediat
hemifus
obtain
quantit
inform
rate
extent
initi
fusion
induc
wt
mutat
f
along
hn
protein
rbc
mix
acceptor
cell
coexpress
wt
mutat
f
hn
glycoprotein
kinet
fluoresc
dequench
probe
measur
use
fluoromet
shown
figur
cell
individu
express
pbsk
f
protein
mix
rbc
fluoresc
dequench
detect
blue
curv
purpl
curv
color
refer
onlin
version
howev
cell
coexpress
wt
f
homolog
hn
protein
fluoresc
dequench
rapidli
significantli
increas
red
curv
color
refer
onlin
version
rate
fluoresc
dequench
calcul
maximum
slope
curv
shown
figur
b
normal
maximum
rate
fusion
induc
wt
f
hn
protein
fig
c
maximum
extent
fluoresc
dequench
min
calcul
kinet
curv
shown
figur
b
express
percent
activ
rel
level
wt
f
hn
protein
fig
cell
coexpress
singl
mutant
protein
doubl
mutant
protein
tripl
mutant
protein
along
hn
protein
mix
rbc
almost
fluoresc
dequench
observ
rate
extent
hemifus
less
wt
f
hn
level
initi
rate
fusion
mutat
f
protein
coexpress
hn
protein
respect
extent
dequench
min
respect
addit
initi
rate
extent
fusion
cell
cotransfect
hn
gene
reduc
wt
level
valu
lower
cell
cotransfect
wt
f
hn
gene
consist
result
obtain
syncytium
format
assay
contentmix
assay
dye
transfer
assay
result
spectrofluorometr
analysi
lipid
mix
show
mutat
f
protein
reduc
rate
extent
hemifus
therefor
mutat
leucin
zipperlik
motif
f
protein
coexpress
homolog
hn
protein
diminish
fusion
activ
variou
degre
stage
membran
fusion
inspect
whether
alanin
substitut
leucin
zipperlik
motif
diminish
even
abolish
result
express
mean
sd
independ
experi
p
p
p
fusion
activ
affect
express
level
mutat
f
protein
surfac
transient
transfect
cell
fluorescenceactiv
cell
sort
fac
analysi
perform
antif
monoclon
antibodi
describ
materi
method
level
mutat
f
protein
transport
cell
surfac
indic
mean
fluoresc
intens
valu
mutant
percentag
wt
f
subtract
background
shown
figur
mutat
f
protein
express
cell
surfac
level
quit
compar
wt
f
protein
result
indic
mutat
f
protein
retain
abil
effici
traffick
cell
surfac
probe
whether
mutat
f
protein
leucin
zipperlik
motif
weaken
membran
fusion
activ
alter
interact
hn
f
proa
b
fig
hemifus
direct
wt
mutat
f
protein
coexpress
hn
protein
dye
transfer
detect
describ
materi
method
spread
fluoresc
red
blood
cell
membran
underli
transfect
cell
membran
imag
monitor
fluoresc
microscopi
repres
photomicrograph
dye
transfer
caus
wt
mutat
f
protein
presenc
hn
dye
transfer
event
indic
arrow
b
quantif
dye
transfer
caus
mutat
f
protein
extent
dye
transfer
express
averag
number
dye
transfer
event
microscop
field
p
p
p
intervirolog
doi
tein
cell
surfac
modifi
coimmunoprecipit
assay
use
determin
amount
f
brought
extract
hnfcotransfect
cell
interact
hn
mixtur
antihn
monoclon
antibodi
f
protein
exist
immunoprecipit
detect
western
blot
analysi
use
antif
monoclon
antibodi
hn
protein
detect
separ
western
blot
analysi
use
antihn
monoclon
antibodi
critic
control
assay
shown
figur
first
lane
show
neither
protein
immunoprecipit
control
cell
transfect
empti
vector
second
lane
demonstr
f
protein
immunoprecipit
mixtur
antihn
monoclon
antibodi
extract
cell
individu
express
f
protein
third
lane
demonstr
protein
coimmunoprecipit
hn
present
cell
transfect
f
gene
control
establish
specif
coimmunoprecipit
f
antihn
antibodi
rel
level
coimmunoprecipit
f
protein
extract
cell
coexpress
mutat
f
hn
protein
express
percentag
coimmunoprecipit
extract
contain
wt
f
hn
protein
detect
coimmunoprecipit
f
protein
tripl
mutant
consist
lost
fusogen
activ
three
singl
mutant
protein
fusion
activ
wt
level
coimmunoprecipit
antihn
monoclon
antibodi
wt
f
amount
three
doubl
mutant
protein
exhibit
fusion
activ
similar
coimmunoprecipit
less
half
wt
f
protein
mutant
f
protein
signific
effect
fusion
activ
retain
wt
f
level
could
coimmunoprecipit
wt
level
respect
addit
mutant
fuse
wt
level
coimmunoprecipit
wt
f
level
taken
togeth
result
impli
reduct
fusion
activ
correl
defect
abil
mutat
f
protein
interact
hn
protein
cell
surfac
leucin
zipper
motif
contain
period
repeat
leucin
isoleucin
residu
everi
amino
acid
found
import
effect
membran
fusion
paramyxovirus
one
leucin
zipper
motif
paramyxoviru
fusion
protein
analyz
role
motif
locat
hra
hrb
f
protein
fusogen
activ
perform
sitedirect
mutagenesi
substitut
heptad
leucin
residu
alanin
residu
either
singli
combin
cell
surfac
express
interact
f
hn
protein
may
affect
fusion
activ
f
protein
also
analyz
interestingli
mutant
motif
exhibit
decreas
fusion
activ
studi
use
differ
type
membran
fusion
assay
quantit
analyz
effect
mutat
motif
fusogen
activ
f
protein
result
indic
amino
acid
residu
posit
either
end
leucin
zipperlik
domain
display
extrem
exhaust
fusion
activ
stage
fusion
process
replac
alanin
one
nonexclus
possibl
key
residu
stabil
structur
motif
also
involv
fusion
mutant
retain
fusion
activ
compar
wt
f
protein
appear
residu
much
toler
alanin
substitut
one
locat
either
end
motif
without
significantli
affect
fusogen
shown
figur
comparison
primari
amino
acid
sequenc
leucin
zipperlik
motif
differ
paramyxoviru
f
protein
suggest
middl
heptad
leucin
residu
highli
conserv
analysi
heptad
leucin
replac
individu
combin
alanin
reveal
singl
substitut
abl
diminish
fusion
activ
protein
replac
combin
could
reduc
even
abrog
fusion
activ
data
agreement
result
mutat
analysi
leucin
zipper
domain
murin
coronaviru
spike
protein
substitut
least
heptad
leucin
residu
necessari
abrog
fusion
activ
sinc
mutant
exhibit
similar
level
cell
surfac
express
respect
wt
f
protein
lack
fusion
activ
could
account
insuffici
amount
f
protein
avail
cell
surfac
tradit
membran
fusion
divid
sequenti
stage
hemifus
first
step
merger
outer
leaflet
target
effector
lipid
bilay
measur
assay
pore
format
follow
hemifus
result
mix
outer
inner
leaflet
membran
lipid
concomit
mix
aqueou
content
measur
report
gene
assay
pore
expans
final
stage
lead
format
multinucl
giant
cell
measur
syncytium
format
assay
c
b
fig
coimmunoprecipit
wt
mutat
f
protein
attach
protein
surfac
protein
cell
transfect
desir
plasmid
biotinyl
cell
lyse
dynabeadshn
abhn
agf
ag
immun
complex
form
dynabeadscrosslink
antihn
antibodi
wash
suffici
resuspend
pb
incub
streptavidin
bead
describ
materi
method
precipit
cell
surfac
complex
coimmunoprecipit
f
protein
complex
detect
western
blot
analysi
antif
monoclon
antibodi
top
hn
protein
detect
use
mixtur
antihn
monoclon
antibodi
bottom
protein
electrophores
presenc
reduc
agent
critic
control
coimmunoprecipit
assay
negc
empti
vector
hn
f
plasmid
alon
fwt
wt
f
protein
hn
protein
b
c
result
coimmunoprecipit
assay
protein
carri
alanin
substitut
leucin
zipperlik
motif
wt
f
protein
mutant
indic
cotransfect
hn
indic
gel
quantif
analysi
b
c
use
densitometri
method
independ
experi
data
shown
mean
sd
p
p
six
mutat
f
protein
nearli
lost
abil
form
syncytia
direct
less
level
pore
format
wt
f
protein
exhibit
hemifus
activ
almost
similar
neg
control
level
rate
extent
initi
fusion
wt
f
level
minim
level
hemifus
low
level
pore
format
almost
neg
control
level
syncytium
format
detect
mutant
suggest
low
level
syncytium
format
like
due
slow
fusion
kinet
unabl
effici
support
pore
expans
paramyxoviru
system
includ
membran
fusion
requir
hn
f
protein
deriv
homolog
virus
suggest
virusspecif
interact
membran
glycoprotein
crucial
induct
cell
fusion
upon
attach
hn
protein
sialic
acid
receptor
hn
protein
undergo
conform
chang
stimul
associ
f
protein
refold
postfus
conform
studi
show
mutat
leucin
zipperlik
motif
f
protein
diminish
even
abrog
fusion
activ
also
reduc
amount
hnf
complex
seem
correl
fusion
defici
decreas
abil
f
interact
hn
result
seem
line
find
melanson
iorio
thu
reason
explan
defect
fusion
activ
mutant
f
protein
fail
form
suffici
amount
function
complex
contain
hn
protein
therebi
block
signal
transmiss
hn
f
protein
signal
presum
involv
modul
membran
fusion
process
report
domain
b
f
protein
region
f
protein
involv
hnf
interact
correspond
region
motif
f
protein
f
protein
identifi
includ
domain
amino
acid
sequenc
align
present
find
thu
exclud
possibl
motif
per
se
constitu
specif
interact
domain
hn
summari
substitut
introduc
leucin
zipperlik
motif
locat
hra
hrb
f
protein
result
mutant
defect
fusion
activ
stage
fusion
process
mutant
form
replac
highli
conserv
middl
heptad
leucin
residu
combin
singl
mutant
end
motif
drastic
diminish
even
abrog
fusogen
activ
base
find
propos
leucin
zipperlik
motif
f
glycoprotein
import
effect
fusion
activ
integr
motif
indispens
membran
fusion
studi
influenc
motif
f
protein
fusion
activ
could
provid
clue
develop
antivir
vaccin
therapeut
drug
prevent
cure
paramyxoviru
infect
